Literature DB >> 11306008

Cyclic AMP-mediated signaling components are upregulated in the prefrontal cortex of depressed suicide victims.

Y Odagaki1, J A García-Sevilla, P Huguelet, R La Harpe, T Koyama, J Guimón.   

Abstract

The components of cyclic AMP signaling cascade (catalytic (Calpha) subunit of cyclic AMP-dependent protein kinase (PKA) and cyclic AMP response element binding protein (CREB)) were quantitated by Western blotting in the prefrontal cortex of depressed suicide victims (n=23) and their matched controls (n=14). There was a significant increase in the levels of CREB, both in total (tCREB; 121+/-8% (mean+/-S.E.M.), P<0.02) and phosphorylated (pCREB; 128+/-9%, P<0.01) forms, but not in PKA Calpha levels (109+/-9%, ns), in brains of depressed suicides compared to those in control subjects. The increases in CREB were specifically observed in antidepressant drug-free subjects (tCREB: 137+/-11%, P<0.01; pCREB: 136+/-12%, P<0.02; n=9), but not in the antidepressant-treated subjects (tCREB: 108+/-18%, ns; pCREB: 111+/-17%, ns; n=8). There were significant correlations between the levels of PKA and those of tCREB and pCREB in the prefrontal cortex of depressed suicides. These results indicate that the components of cyclic AMP signaling are upregulated in a coordinated manner in brains of depressed suicides and that this alteration is not related to antidepressant treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306008     DOI: 10.1016/s0006-8993(01)02188-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

Review 1.  Pharmacogenomics of suicidal events.

Authors:  David Brent; Nadine Melhem; Gustavo Turecki
Journal:  Pharmacogenomics       Date:  2010-06       Impact factor: 2.533

2.  Long-term upregulation of protein kinase A and adenylate cyclase levels in human smokers.

Authors:  Bruce T Hope; Deepti Nagarkar; Sherry Leonard; Roy A Wise
Journal:  J Neurosci       Date:  2007-02-21       Impact factor: 6.167

3.  CREB1 gene polymorphisms combined with environmental risk factors increase susceptibility to major depressive disorder (MDD).

Authors:  Peng Wang; Yanjie Yang; Xiuxian Yang; Xiaohui Qiu; Zhengxue Qiao; Lin Wang; Xiongzhao Zhu; Hong Sui; Jingsong Ma
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 4.  Elucidating biological risk factors in suicide: role of protein kinase A.

Authors:  Yogesh Dwivedi; Ghanshyam N Pandey
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-09-09       Impact factor: 5.067

5.  Cyclic-AMP response element binding protein (CREB) in the neutrophils of depressed patients.

Authors:  Xinguo Ren; Yogesh Dwivedi; Amal C Mondal; Ghanshyam N Pandey
Journal:  Psychiatry Res       Date:  2010-05-23       Impact factor: 3.222

6.  5-Lipoxygenase in the Prefrontal Cortex of Suicide Victims.

Authors:  Tolga Uz; Yogesh Dwivedi; Ghanshyam N Pandey; Rosalinda C Roberts; Robert R Conley; Radmila Manev; Hari Manev
Journal:  Open Neuropsychopharmacol J       Date:  2008-01-01

7.  Diverse antidepressants increase CDP-diacylglycerol production and phosphatidylinositide resynthesis in depression-relevant regions of the rat brain.

Authors:  Kimberly R Tyeryar; Habiba O U Vongtau; Ashiwel S Undieh
Journal:  BMC Neurosci       Date:  2008-01-24       Impact factor: 3.288

8.  Candidate genes for antidepressant response to selective serotonin reuptake inhibitors.

Authors:  Francis E Lotrich; Bruce G Pollock
Journal:  Neuropsychiatr Dis Treat       Date:  2005-03       Impact factor: 2.570

9.  Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain.

Authors:  Patrick O McGowan; Aya Sasaki; Tony C T Huang; Alexander Unterberger; Matthew Suderman; Carl Ernst; Michael J Meaney; Gustavo Turecki; Moshe Szyf
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240

10.  Adenylyl cyclase-cyclicAMP signaling in mood disorders: role of the crucial phosphorylating enzyme protein kinase A.

Authors:  Yogesh Dwivedi; Ghanshyam N Pandey
Journal:  Neuropsychiatr Dis Treat       Date:  2008-02       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.